Case report: A lung squamous cell carcinoma patient with a rare EGFR G719X mutation and high PD-L1 expression showed a good response to anti-PD1 therapy

Case report: A lung squamous cell carcinoma patient with a rare EGFR G719X mutation and high PD-L1 expression showed a good response to anti-PD1 therapy

Lung cancer treatment has transitioned fully into the era of immunotherapy, yielding substantial improvements in survival rate for patients with advanced non-small cell lung cancer (NSCLC). In this report, we present a case featuring a rare epidermal growth factor receptor (EGFR) mutation accompanie...

Full description

Bibliographic Details
Main Authors: Zhen-feng Zhu, Xu-xia Bao, Hong-yan Shi, Xi-xi Gu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Oncology
Subjects:
lung squamous cell carcinoma
EGFR G719X mutation
anti-PD1 therapy
afatinib
inflammatory microenvironment
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1283008/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1283008/full

Similar Items